Showing results (1-10 of 989) with videos related to
Sort By:
Pageof 99
Therapeutic Advances in Respiratory Disease|December 9, 2022
Clinical significance of acute exacerbation in interstitial lung disease with antineutrophil cytoplasmic antibody: an indicator of poor prognosisTingting Wu, Yun Zhang, Zekai Cen, et al.Therapeutic Advances in Respiratory Disease|October 19, 2020
Risk factors for early readmission after acute exacerbation of chronic obstructive pulmonary diseaseYong Suk Jo, Chin Kook Rhee, Kyung Joo Kim, et al.Therapeutic Advances in Respiratory Disease|February 29, 2020
Efficacy and safety of revefenacin for nebulization in patients with chronic obstructive pulmonary disease taking concomitant ICS/LABA or LABA: subgroup analysis from phase III trialsSanjay Sethi, James F Donohue, Gary T Ferguson, et al.Therapeutic Advances in Respiratory Disease|December 23, 2022
Impact of elexacaftor/tezacaftor/ivacaftor on depression and anxiety in cystic fibrosisLijia Zhang, Dana Albon, Marieke Jones, et al.Therapeutic Advances in Respiratory Disease|November 29, 2022
Combination of anti-glycopeptidolipid-core IgA antibody and clinical features for diagnosing potential nontuberculous mycobacterium pulmonary disease in routine practiceTakuya Iwasaki, Fumihiro Yamaguchi, Makoto Hayashi, et al.Therapeutic Advances in Respiratory Disease|June 24, 2022
Mortality association of nontuberculous mycobacterial infection requiring treatment in Taiwan: a population-based studyHsin-Hua Chen, Ching-Heng Lin, Wen-Cheng ChaoTherapeutic Advances in Respiratory Disease|October 11, 2021
The predictive role of lymphocyte subsets and laboratory measurements in COVID-19 disease: a retrospective studyLin Wang, Jun Chen, Jun Zhao, et al.Therapeutic Advances in Respiratory Disease|April 29, 2022
Microvascular injuries, secondary edema, and inconsistencies in lung vascularization between affected and nonaffected pulmonary segments of non-critically ill hospitalized COVID-19 patients presenting with clinical deteriorationCécile Maincent, Christophe Perrin, Gilles Chironi, et al.Therapeutic Advances in Respiratory Disease|April 18, 2022
Uncontrolled asthma predicts severe COVID-19: a report from the Swedish National Airway RegisterJohanna Karlsson Sundbaum, Jon R Konradsen, Lowie E G W Vanfleteren, et al.Therapeutic Advances in Respiratory Disease|October 8, 2010
The relationship between gastroesophageal reflux and asthma: an updateJennifer W McCallister, Jonathan P Parsons, John G MastronardePageof 99